VRTX
VERTEX PHARMACEUTICALS INC / MAA8715-min delayed · EOD close——as of —
Pharmaceutical Preparations · SIC 2834 · CIK 0000875320
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $12.6B | 2026-06-30 | 10-Q · 0000875320-26-000259 |
| Revenue (prior year) | $11.0B | 2024-12-31 | 10-K · 0000875320-25-000053 |
| Operating income | $4.8B | 2026-06-30 | 10-Q · 0000875320-26-000259 |
| Net income | $4.4B | 2026-06-30 | 10-Q · 0000875320-26-000259 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $27.4B | 2026-06-30 | 10-Q · 0000875320-26-000259 |
| Current assets | $12.5B | 2026-06-30 | 10-Q · 0000875320-26-000259 |
| Total liabilities | $7.2B | 2026-06-30 | 10-Q · 0000875320-26-000259 |